Francisco Bizouarn of the Bio-Rad Digital Biology Center provides an overview of Droplet Digital™ PCR technology from technical and workflow-related perspectives and reviews key applications.
Jennifer Berman of Bio-Rad Laboratories presents rapid, low-cost ddPCR methods that enable the detection of gene-edited alleles at unprecedented low frequency.
Philip Chapman of Bio-Rad Laboratories discusses the advantages of automated multidimensional (Multi-D) chromatography compared to traditional multistep purification strategies.
In this presentation, Dr. James Mapes details how Bio-Plex Pro™ Human RBM Metabolic and Hormone Assays can be used to assess multiple protein biomarkers associated with diabetes and metabolic conditions linked to cardiovascular diseases. Learn what biomarkers are currently under investigation and why rigorous assay validation is critical.
Dr. Robyn Murphy of Latrobe University introduces a protocol using Bio-Rad’s stain-free gel technology to conduct western blotting on sample sizes as small as single muscle cells. Dr. Murphy shows how this reliable western blotting method can be a valuable research tool. Learn more about stain-free technology.
Prof. Aldrin Gomes of UC Davis shares western blot problems he has seen as a journal editor and outlines standardized procedures and controls needed to make western blotting data reliable. The presentation also includes tips to save time and labor during the blotting procedure.
Join Dr. Yann Jouvenot for this overview of Bio-Rad’s Droplet Digital PCR (ddPCR™) System. Learn about the principles, unique characteristics, and applications of the technology and find out how it can be used to complement existing techniques in gene expression studies and microRNA analysis.
In this webinar presented by Dr. Jennifer Berman, learn how Droplet Digital PCR (ddPCR™) technology uses a simple, cost-effective workflow to accurately and reproducibly assess copy number variations (CNVs) even in high-throughput settings.
This presentation by Dr. Dawne Shelton describes how Droplet Digital PCR (ddPCR™) can be used to measure circulating nucleic acids (cfDNA) and circulating tumor cells (CTCs) in blood and to detect rare tumorigenic mutations down to 0.01% or less in a high background of normal DNA. Techniques and methods discussed in this webinar will enable you to begin your own investigations.